{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:42:24Z","timestamp":1773898944945,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003645","name":"National Cancer Center, Korea","doi-asserted-by":"crossref","award":["NCC 1710160-1"],"award-info":[{"award-number":["NCC 1710160-1"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5922-8","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T13:03:26Z","timestamp":1563800606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The optimal extent of lymph node dissection in gastroesophageal junctional cancer: retrospective case control study"],"prefix":"10.1186","volume":"19","author":[{"given":"Won Ho","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bang Wool","family":"Eom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Man","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Reim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Mog","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0332-2051","authenticated-orcid":false,"given":"Keun Won","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,22]]},"reference":[{"key":"5922_CR1","doi-asserted-by":"crossref","unstructured":"Committee of Korean Gastric Cancer Association.\u00a0Korean gastric Cancer association Nationwide survey on gastric Cancer in 2014. J Gastric Cancer. 2016;16:131\u201340.","DOI":"10.5230\/jgc.2016.16.3.131"},{"key":"5922_CR2","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1111\/j.1440-1746.2008.05572.x","volume":"23","author":"C Kusano","year":"2008","unstructured":"Kusano C, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol. 2008;23:1662\u20135.","journal-title":"J Gastroenterol Hepatol"},{"key":"5922_CR3","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1046\/j.1365-2168.1998.00940.x","volume":"85","author":"JR Siewert","year":"1998","unstructured":"Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85:1457\u20139.","journal-title":"Br J Surg"},{"issue":"12","key":"5922_CR4","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1245\/s10434-010-1362-z","volume":"17","author":"Kay Washington","year":"2010","unstructured":"Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17:3077\u20139.","journal-title":"Annals of Surgical Oncology"},{"key":"5922_CR5","doi-asserted-by":"publisher","first-page":"E282","DOI":"10.21037\/jtd.2017.03.39","volume":"9","author":"CL Donohoe","year":"2017","unstructured":"Donohoe CL, Phillips AW. Cancer of the esophagus and esophagogastric junction: an 8th edition staging primer. J Thorac Dis. 2017;9:E282\u2013e4.","journal-title":"J Thorac Dis"},{"key":"5922_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s11748-014-0381-2","volume":"62","author":"T Matsuda","year":"2014","unstructured":"Matsuda T, et al. Optimal surgical management for esophagogastric junction carcinoma. Gen Thorac Cardiovasc Surg. 2014;62:560\u20136.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"5922_CR7","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00268-017-3880-3","volume":"41","author":"T Matsuda","year":"2017","unstructured":"Matsuda T, Takeuchi H. Clinicopathological characteristics and prognostic factors of patients with Siewert type II Esophagogastric junction carcinoma: a retrospective multicenter study: reply. World J Surg. 2017;41:1395.","journal-title":"World J Surg"},{"key":"5922_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10120-016-0663-8","volume":"20","author":"H Yamashita","year":"2017","unstructured":"Yamashita H, et al. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer. 2017;20:69\u201383.","journal-title":"Gastric Cancer"},{"key":"5922_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1245\/s10434-011-1983-x","volume":"19","author":"Y Hosokawa","year":"2012","unstructured":"Hosokawa Y, et al. Clinicopathological features and prognostic factors of adenocarcinoma of the Esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol. 2012;19:677\u201383.","journal-title":"Ann Surg Oncol"},{"key":"5922_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12957-016-1088-x","volume":"15","author":"IS Lee","year":"2017","unstructured":"Lee IS, et al. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma. World J Surg Oncol. 2017;15:28.","journal-title":"World J Surg Oncol"},{"key":"5922_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.surg.2014.08.099","volume":"157","author":"Y Kurokawa","year":"2015","unstructured":"Kurokawa Y, et al. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction. Surgery. 2015;157:551\u20135.","journal-title":"Surgery"},{"key":"5922_CR12","first-page":"445","volume":"35","author":"K Hosoda","year":"2015","unstructured":"Hosoda K, et al. Impact of lower mediastinal lymphadenectomy for the treatment of esophagogastric junction carcinoma. Anticancer Res. 2015;35:445\u201356.","journal-title":"Anticancer Res"},{"key":"5922_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00595-011-0114-4","volume":"42","author":"Y Kakeji","year":"2012","unstructured":"Kakeji Y, et al. Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection. Surg Today. 2012;42:351\u20138.","journal-title":"Surg Today"},{"issue":"4","key":"5922_CR14","first-page":"304","volume":"67","author":"Thomas W. Rice","year":"2017","unstructured":"Rice TW, et al. Cancer of the esophagus and esophagogastric junction: major changes in the American joint committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;8:304\u201317.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"5922_CR15","doi-asserted-by":"crossref","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113\u201323.","DOI":"10.1007\/s10120-011-0042-4"},{"issue":"2","key":"5922_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"Daniel Dindo","year":"2004","unstructured":"Dindo D, et al. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240.","journal-title":"Annals of Surgery"},{"key":"5922_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00268-008-9740-4","volume":"33","author":"S Hasegawa","year":"2009","unstructured":"Hasegawa S, et al. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center. World J Surg. 2009;33:95\u2013103.","journal-title":"World J Surg"},{"key":"5922_CR18","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/SLA.0b013e31824beb95","volume":"255","author":"YS Suh","year":"2012","unstructured":"Suh YS, et al. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification. Ann Surg. 2012;255:908\u201315.","journal-title":"Ann Surg"},{"key":"5922_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5230\/jgc.2012.12.1.36","volume":"12","author":"KT Kim","year":"2012","unstructured":"Kim KT, et al. Outcomes of abdominal Total gastrectomy for type II and III gastroesophageal junction tumors: single Center's experience in Korea. J Gastric Cancer. 2012;12:36\u201342.","journal-title":"J Gastric Cancer"},{"key":"5922_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10120-017-0746-1","volume":"21","author":"S Blank","year":"2018","unstructured":"Blank S, Schmidt T. Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach? 2017Gastric Cancer. 2018;21:303\u201314.","journal-title":"2017Gastric Cancer"},{"key":"5922_CR21","first-page":"4391","volume":"34","author":"Y Hosokawa","year":"2014","unstructured":"Hosokawa Y, et al. Recurrence patterns of esophagogastric junction adenocarcinoma according to Siewert's classification after radical resection. Anticancer Res. 2014;34:4391\u20137.","journal-title":"Anticancer Res"},{"key":"5922_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/jso.23484","volume":"109","author":"NJ Curtis","year":"2014","unstructured":"Curtis NJ, et al. The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction. J Surg Oncol. 2014;109:202\u20137.","journal-title":"J Surg Oncol"},{"key":"5922_CR23","unstructured":"Sisic L, et al. The postoperative part of perioperative chemotherapy fails to provide a survival benefit in completely resected esophagogastric adenocarcinoma. Surg Oncol. 2017; Epub ahead of print."},{"key":"5922_CR24","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s10120-017-0751-4","volume":"21","author":"L Sisic","year":"2018","unstructured":"Sisic L, et al. Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis. Gastric Cancer. 2018;21:552\u201368.","journal-title":"Gastric Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5922-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5922-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5922-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T23:08:43Z","timestamp":1595286523000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5922-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,22]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5922"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5922-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,22]]},"assertion":[{"value":"22 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. This study was approved by the Institutional Review Board of the National Cancer Center (No.NCC2017\u20130224). The need for and patients\u2019 informed consent was waived given the retrospective nature of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"719"}}